ALK and anaplastic large cell lymphoma: Other notable successes in pediatric solid tumors include targeting the ALK fusions observed in the majority of anaplastic large cell lymphoma (ALCL) and approximately half of the patients with inflammatory myofibroblastic tumors (IMT) [64,65].